Eric Xueyu Chen

17PUBLICATIONS
93CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - inorganic elements and compoundsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory <i>RAS</i>/<i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Jan 22, 2026
Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer.

Dung T Le, Gunnar Folprecht, Anna M Varghese

|Apr 11, 2025
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials.

Danielle Lilly Nicholls, Maria C Xu, Luna Zhan

|Jan 24, 2025
Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependencies.

Alexander P Landry, Justin Z Wang, Leeor S Yefet

|Dec 05, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss

|Dec 04, 2024
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.

Lucy X Ma, Emma Titmuss, Jonathan M Loree

Pageof 3

Frequent Collaborators

4 joint publications

Jonathan M Loree

4 joint publications

Hagen F Kennecke

4 joint publications

Dongsheng Tu

2 joint publications

Kimberly C Banks